Qin Jiang
About
Qin Jiang is a scholar working on Epidemiology, Microbiology and Pharmacology.
According to data from OpenAlex, Qin Jiang has authored 105 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Epidemiology, 26 papers in Microbiology and 15 papers in Pharmacology. Recurrent topics in Qin Jiang's work include Pneumonia and Respiratory Infections (41 papers), Bacterial Infections and Vaccines (25 papers) and Respiratory viral infections research (25 papers). Qin Jiang is often cited by papers focused on Pneumonia and Respiratory Infections (41 papers), Bacterial Infections and Vaccines (25 papers) and Respiratory viral infections research (25 papers). Qin Jiang collaborates with scholars based in United States, China and Canada. Qin Jiang's co-authors include Diane E. Taylor, John L. Perez, Kathrin U. Jansen, Christine J. Guico‐Pabia, Koji Hiratsuka, Thomas R. Jones, Shannon L. Harris, Ge Wang, Alice I. Nichols and Philip T. Ninan and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.
In The Last Decade
Qin Jiang
97 papers receiving 2.8k citations
Peers
Qin Jiang
Kim Kristensen Denmark
Cornelia B. Landersdorfer Australia
Shigeki Nakamura Japan
Vesna Eraković Haber Croatia
F. Sörgel Germany
Jordi Solé‐Violán Spain
Yoshio Uehara Japan
J Weil United Kingdom
Iosif Kelesidis United States
J. D. Baumgartner Switzerland
Citations per year, relative to Qin Jiang Qin Jiang (= 1×)
peers
Kim Kristensen
Countries citing papers authored by Qin Jiang
Since
Specialization
Citations
This map shows the geographic impact of Qin Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qin Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qin Jiang more than expected).
Fields of papers citing papers by Qin Jiang
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Qin Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qin Jiang. The network helps show where Qin Jiang may publish in the future.
Co-authorship network of co-authors of Qin Jiang
This figure shows the co-authorship network connecting the top 25 collaborators of Qin Jiang. A scholar is included among the top collaborators of Qin Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qin Jiang. Qin Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Davis, Mark M., William Towner, Elliot DeHaan, et al.. (2025). P-596. Immunobridging Demonstrating Effectiveness of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine in Adults 18-59 Years of Age at High Risk of Severe RSV Disease in a Phase 3 Trial: The C3671023 MONeT Study Results. Open Forum Infectious Diseases. 12(Supplement_1).
2.
Jiang, Qin, et al.. (2025). Cellular cholesterol metabolism rewiring through SREBP2-LXR-mTOR signaling convergence orchestrates T cell fate and keratinocyte apoptosis in oral lichen planus. International Immunopharmacology. 166. 115457–115457.
3.
Sun, Min, Qin Jiang, Ziwei Zhu, et al.. (2025). Evolutionary Dynamics and Functional Diversification of bZIP Transcription Factors in Cucurbitaceae: A Pan-Genome Approach. Journal of Agricultural and Food Chemistry. 73(50). 32363–32378.
4.
Liu, Haoliang, et al.. (2024). Prediction of TMCCs@MoS2 heterostructures with homogeneous surface terminations as promising anodes for sodium and potassium ion batteries. Computational Materials Science. 248. 113568–113568.
5.
Dreyfus, Jill, Swapna Munnangi, Camilla Bengtsson, et al.. (2024). Background incidence rates of health outcomes in populations at risk for Lyme disease using US administrative claims data. Vaccine. 42(5). 1094–1107.
6.
Sharp, Burt M., et al.. (2020). Allosteric Modulation of GABA A Receptors in Rat Basolateral Amygdala Blocks Stress-Enhanced Reacquisition of Nicotine Self-Administration. ACS Pharmacology & Translational Science. 3(6). 1158–1164.
7.
Xing, Jing, Xue Ji, Yuan Sun, et al.. (2019). Preparation and immunological characterization of an inactivated canineClostridium perfringenstype A vaccine. Letters in Applied Microbiology. 69(5). 385–390.
8.
Campling, James, Dylan Jones, James D. Chalmers, et al.. (2019). The impact of certain underlying comorbidities on the risk of developing hospitalised pneumonia in England. SHILAP Revista de lepidopterología. 11(1). 4–4.
9.
Gessner, Bradford D., Qin Jiang, Cornelis H. van Werkhoven, et al.. (2018). A public health evaluation of 13-valent pneumococcal conjugate vaccine impact on adult disease outcomes from a randomized clinical trial in the Netherlands. Vaccine. 37(38). 5777–5787.
10.
Vesikari, Timo, Lars Østergaard, Javier Díez‐Domingo, et al.. (2015). Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents. Journal of the Pediatric Infectious Diseases Society. 5(2). 152–160.
11.
Nissen, Michael D., Helen Marshall, Peter Richmond, et al.. (2015). A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults. Vaccine. 33(15). 1846–1854.
12.
Lalwani, Sanjay, Ashish Bavdekar, Sundaram Balasubramanian, et al.. (2012). Immunogenicity and Safety of a 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers Given With Routine Vaccines in India. The Pediatric Infectious Disease Journal. 32(5). 509–516.
13.
Campbell, Scott B., Rowan G. Walker, S. See Tai, Qin Jiang, & Graeme R. Russ. (2012). Randomized Controlled Trial of Sirolimus for Renal Transplant Recipients at High Risk for Nonmelanoma Skin Cancer. American Journal of Transplantation. 12(5). 1146–1156.
14.
Tourian, Karen A., Qin Jiang, & Philip T. Ninan. (2010). Analysis of the Effect of Desvenlafaxine on Anxiety Symptoms Associated with Major Depressive Disorder: Pooled Data from 9 Short-Term, Double-blind, Placebo-Controlled Trials. CNS Spectrums. 15(3). 187–193.
15.
Kornstein, Susan G., Qin Jiang, Sujana Reddy, Jeff Musgnung, & Christine J. Guico‐Pabia. (2010). Short-Term Efficacy and Safety of Desvenlafaxine in a Randomized, Placebo-Controlled Study of Perimenopausal and Postmenopausal Women With Major Depressive Disorder. The Journal of Clinical Psychiatry. 71(8). 1088–1096.
16.
Liu, Weihua, Xiaoyan Zhang, Peiqing Liu, et al.. (2010). Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury. European Journal of Pharmacology. 638(1-3). 150–155.
17.
Soares, Cláudio N., Susan G. Kornstein, Michael E. Thase, Qin Jiang, & Christine J. Guico‐Pabia. (2009). Assessing the Efficacy of Desvenlafaxine for Improving Functioning and Well-Being Outcome Measures in Patients With Major Depressive Disorder. The Journal of Clinical Psychiatry. 70(10). 1365–1371.
18.
Schmitt, Andreas, et al.. (2009). Differential effects of venlafaxine in the treatment of major depressive disorder according to baseline severity. European Archives of Psychiatry and Clinical Neuroscience. 259(6). 329–339.
19.
Akopyants, Natalia S., Qin Jiang, Diane E. Taylor, & Douglas E. Berg. (1997). Corrected Identity of Isolates of Helicobacter Pylori Reference Strain NCTC11637. Helicobacter. 2(1). 48–52.
20.
Jiang, Qin, Koji Hiratsuka, & Diane E. Taylor. (1996). Variability of gene order in different Helicobacter pylori strains contributes to genome diversity. Molecular Microbiology. 20(4). 833–842.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Kim Kristensen Breakdown of academic impact, for papers by Cornelia B. Landersdorfer Breakdown of academic impact, for papers by Shigeki Nakamura Breakdown of academic impact, for papers by Vesna Eraković Haber Breakdown of academic impact, for papers by F. Sörgel Breakdown of academic impact, for papers by Jordi Solé‐Violán Breakdown of academic impact, for papers by Yoshio Uehara Breakdown of academic impact, for papers by J Weil Breakdown of academic impact, for papers by Iosif Kelesidis Breakdown of academic impact, for papers by J. D. Baumgartner